These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prognostic value of insulin- like growth factor-I receptor expression in renal cell carcinoma. Sichani MM; Yazdi FS; Moghaddam NA; Chehrei A; Kabiri M; Naeimi A; Taheri D Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):69-74. PubMed ID: 20061696 [TBL] [Abstract][Full Text] [Related]
5. Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma. Parker AS; Cheville JC; Lohse CM; Igel T; Leibovich BC; Blute ML Urology; 2005 Jun; 65(6):1090-5. PubMed ID: 15893810 [TBL] [Abstract][Full Text] [Related]
6. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma. Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498 [TBL] [Abstract][Full Text] [Related]
7. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival. Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115 [TBL] [Abstract][Full Text] [Related]
8. Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma. Jorns JJ; Thiel DD; Lohse C; Williams A; Arnold M; Cheville J; Leibovich B; Parker AS Urology; 2012 Jul; 80(1):147-50. PubMed ID: 22748870 [TBL] [Abstract][Full Text] [Related]
9. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications. Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334 [TBL] [Abstract][Full Text] [Related]
10. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Sengupta S; Lohse CM; Leibovich BC; Frank I; Thompson RH; Webster WS; Zincke H; Blute ML; Cheville JC; Kwon ED Cancer; 2005 Aug; 104(3):511-20. PubMed ID: 15973740 [TBL] [Abstract][Full Text] [Related]
11. High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma. Parker AS; Kosari F; Lohse CM; Houston Thompson R; Kwon ED; Murphy L; Riehle DL; Blute ML; Leibovich BC; Vasmatzis G; Cheville JC Cancer; 2006 Jul; 107(1):37-45. PubMed ID: 16736510 [TBL] [Abstract][Full Text] [Related]
12. The expression of insulin-like growth factor-I receptor correlates with Fuhrman grading of renal cell carcinomas. Ahmad N; Keehn CA; Coppola D Hum Pathol; 2004 Sep; 35(9):1132-6. PubMed ID: 15343516 [TBL] [Abstract][Full Text] [Related]
13. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492 [TBL] [Abstract][Full Text] [Related]
14. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy. Harada K; Miyake H; Kusuda Y; Fujisawa M BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma. Parker A; Lohse C; Cheville J; Leibovich B; Igel T; Blute M Int J Urol; 2008 Apr; 15(4):304-8. PubMed ID: 18380816 [TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable. Shindo T; Masumori N; Kobayashi K; Fukuta F; Hirobe M; Tonooka A; Hasegawa T; Kitamura H; Tsukamoto T BJU Int; 2013 May; 111(6):941-5. PubMed ID: 23350965 [TBL] [Abstract][Full Text] [Related]
17. Glucose-regulated protein 78 positivity as a predictor of poor survival in patients with renal cell carcinoma. Kuroda K; Horiguchi A; Asano T; Ito K; Asakuma J; Sato A; Yoshii H; Hayakawa M; Sumitomo M; Asano T Urol Int; 2011; 87(4):450-6. PubMed ID: 22076227 [TBL] [Abstract][Full Text] [Related]
18. Increased BTB-Kelch type substrate adaptor protein immunoreactivity associates with advanced stage and poor differentiation in renal cell carcinoma. Ronkainen H; Vaarala MH; Kauppila S; Soini Y; Paavonen TK; Rask J; Hirvikoski P Oncol Rep; 2009 Jun; 21(6):1519-23. PubMed ID: 19424632 [TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of intratumoral C-reactive protein expression in patients with clear cell renal cell carcinoma. Can C; Acikalin MF; Ozen A; Dundar E Urol Int; 2014; 92(3):270-5. PubMed ID: 24356040 [TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma. Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]